With a growing number of biological matrices on the market, the practical question for reconstructive surgeons is how to compare them on properties that matter rather than on branding. This article offers a structured framework for evaluating a biological matrix. It is a general decision aid for professional context, not a recommendation or a substitute for device instructions for use and current evidence.
1. Mechanical properties
The matrix must do a mechanical job: support the implant, hold a defined pocket and retain sutures. Relevant characteristics include tensile strength, tear and suture-retention behaviour, thickness and elasticity. These matter most in prepectoral reconstruction, where the matrix carries more of the load. The organised collagen of bovine pericardium is a strong performer on these axes.
2. Integration and revascularisation
A defining question: is the matrix designed and shown to be repopulated and revascularised, or does it tend to be encapsulated? Constructive remodelling into vascularised host tissue is generally the goal. Bilayer or surface-engineered designs — such as ExaShape, which is engineered to encourage fibroblast activity and neovascularisation — aim specifically at this property.
3. Processing and sterility
Decellularisation method affects both immunogenicity and how well the scaffold structure is preserved. Terminal sterilisation method and biological cleanliness bear on infection risk and shelf handling. Ask what the processing is, what it removes, and what it preserves.
4. Consistency and supply
Batch-to-batch uniformity supports predictable intraoperative behaviour. Manufactured xenografts made to specification tend to offer more consistency than donor-dependent tissue, and supply reliability is a practical operational factor.
5. Regulatory status and evidence
In Europe, regulatory status under the medical device framework (including CE marking and MDR classification) is a baseline requirement. Beyond that, evaluate the product’s own clinical and preclinical evidence — not category-level extrapolation, as discussed in our evidence appraisal article.
6. Handling and workflow
Practical factors — rehydration/preparation requirements, drapability, ease of trimming and fixation, available sizes — affect operative time and reproducibility. A material that behaves predictably on the table is easier to use well.
A simple way to apply the framework
For any matrix you are considering, score it briefly against these six dimensions and note where the evidence is product-specific versus extrapolated. The exercise quickly separates materials that merely claim integration from those designed and evidenced for it, and clarifies trade-offs for your particular technique and patient mix.
The bottom line
Choosing a biological matrix is a multi-dimensional decision: mechanical performance, integration, processing, consistency, regulatory status and evidence, and handling. Evaluating each product on these axes — rather than treating “biological matrix” as one interchangeable thing — leads to better-matched choices. See matrix vs. ADM vs. mesh and the med-tech overview for context, or explore ExaShape against this framework.
This is a general professional decision aid, not a recommendation or clinical guidance. Refer to device instructions for use and current evidence.
